| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 20 |
| 1 | DALFAMPRIDINE | 11 |
| 2 | OFATUMUMAB | 8 |
| 3 | CYCLOPHOSPHAMIDE | 7 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 7 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 7 |
| 6 | RITUXIMAB | 7 |
| 7 | FOLIC ACID | 6 |
| 8 | METHOTREXATE | 6 |
| 9 | METHOTREXATE SODIUM | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORAMPHENICOL SODIUM SUCCINATE | 1 | 0.0303 |
| 1 | ESTRIOL | 4 | 0.0022 |
| 2 | OCRELIZUMAB | 20 | 0.0003 |
| 3 | OFATUMUMAB | 8 | 0.0002 |
| 4 | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | 4 | 0.0002 |
| 5 | CEFOTAXIME INJECTION | 1 | 0.0002 |
| 6 | ALEMTUZUMAB | 4 | 0.0002 |
| 7 | CEFUROXIME | 2 | 0.0002 |
| 8 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 4 | 0.0002 |
| 9 | DALFAMPRIDINE | 11 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 34 |
| 1 | Corticosteroid [EPC] | 12 |
| 2 | Potassium Channel Blocker [EPC] | 11 |
| 3 | Alkylating Drug [EPC] | 7 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 5 | Vitamin C [EPC] | 7 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 6 |
| 7 | Vitamin B12 [EPC] | 6 |
| 8 | Vitamin D [EPC] | 6 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nitrofuran Antibacterial [EPC] | 4 | 0.0002 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 2 | Potassium Channel Blocker [EPC] | 11 | 0.0002 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 34 | 0.0001 |
| 4 | Penem Antibacterial [EPC] | 3 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 6 | Bile Acid [EPC] | 1 | 0.0000 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 5 | 0.0000 |
| 8 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 9 | Azole Antifungal [EPC] | 5 | 0.0000 |